Although antiretroviral therapy is effective in suppressing HIV-1 replication, it does not eradicate the virus and it requires lifelong adherence to the therapy. Authors of a new study say that bNAbs may be the key.
Combining the common cold virus and a DNA-based vaccine revs up the immune system to fight the human immunodeficiency virus (HIV), according to a team of researchers from the University of Adelaide in South Australia.
New hepatitis C treatments made accessible through competition and other access strategies have been given to over one million patients in as many as 13 low-and middle-income countries, according to a new report from the World Health Organization (WHO).
At IDWeek 2016, Mark Murphy, DO, Advocate Children's discussed his team's quality improvement project to improve the HPV vaccine completion rates in pediatric patients, which is an "ongoing national issue".